Login
Toggle navigation
Videos
Categories
Trending
Night of Sciences' at X-FAB Erfurt | Manfred Riemer, CEO, X Fab Silicon Foundries EVXFAB:PAR
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Manfred Riemer is the CEO of this renowned company
Recent Videos
00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
Suggestions
00:10:00
Thundelarra Exploration Highlights Promising Drilling Results in Western Australia
00:10:00
Exploration to Expansion: Gimlet Resources’ Strategic Growth through M&A
00:10:00
Redefining Finance with Silicon Valley Spirit | Marc Lipschultz , co-founder , Blue Owl Capital .
00:10:00
CEO Kenneth Bockhorst in Conversation at The Edgewater Hotel | Kenneth C. Bockhorst - CEO of Badger Meter
00:10:00
The go-to-market plan for BrainChip Holdings' neuromorphic artificial intelligence chips is described | Sean Hehir, CEO, Brainchip Holdings Ltd BRN:ASX
00:10:00
Protecting Family Assets Through Limited Partnerships: Insights from Garrett Sutton of Corporate Direct | Garrett Sutton - Asset Protection Expert, Corporate Direct
00:10:00
Navigating Capital Flows and Market Transformations: Insights from Leading Experts | David Hunt, CEO, PGIM, the Global Investment Management Businesses of Prudential Financial, Inc.
00:10:00
Quadria Capital’s Amit Varma on Raising a Second Healthcare Fund and Industry Trends | Amit Varma, Managing Partner, Quadria Capital.
00:10:00
Apex Gold: Unveiling Greenland's High-Grade Potential at One-to-One London Conference
00:10:00
Alternative Asset Manager Explores Growth Opportunities in Renewable Energy and Infrastructure Investments | Bruce Flatt, CEO,Brookfield Asset Management.
00:10:00
Shri Rajkumar Kamat Shares Insights on EP Biocomposites Ltd's BSE SME Listing | Shri Rajkumar Kamat, Chairman , EP Biocomposites Ltd.
00:10:00
Wes Edens on Brightline's Growth and Future Prospects |Wes Edens, Co-Founder, Fortress Investment.